Cargando…
Factors associated with positive and negative recommendations for cancer and non-cancer drugs for rare diseases in Canada
BACKGROUND: In Canada, reimbursement recommendations on drugs for common and rare diseases are overseen by the Canadian Agency for Drugs and Technologies in Health (CADTH) and made through the pan-Canadian Oncology Drug Review (pCODR) and the Common Drug Review (CDR). While the agency specifies info...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555917/ https://www.ncbi.nlm.nih.gov/pubmed/31174574 http://dx.doi.org/10.1186/s13023-019-1104-7 |